Methods for treating neoplastic, angiogenic, fibroblastic, and/or immunosuppressive ocular irregularities via administration of methotrexate based medicaments, and ocular iontophoretic devices for delivering methotrexate based medicament
US2005153994A1
The use of 5-fluorourcil, delivered by iontophoresis as an inhibitor of cell proliferation in the eye, bulbar and palpebral conjunctiva, eyelid, peri-orbital soft tissues and skin
EP1443931A1
Ocular iontophoretic device for delivering methotrexate based medicaments and use thereof to treat neoplastic, angiogenic, fibroplastic, and/or immunosuppresive ocular irregularities
AU2002316724A1
Ophthalmic use of 5 fluorourcil
WO03008036A2
Ocular ionthophoretic device and method for using the same
US6823202B2
Iontophoretic power supply
US6953446B2
Method and device for the iontophoretic delivery of a drug
US7252655B2
Ocular iontophoretic apparatus handle
US6539251B2
Ocular iontophoretic apparatus
US6488428B1
Fluid assembly containing a breaking component for release of fluid and method therefore
US6546284B2
Fluid retention assembly for an iontophoretic delivery device and associated method for preparing the same
US6697668B2
Ocular iontophoretic device and method for using the same
US6731977B2
Iontophoretic electrode with improved current distribution
US6579276B2
Ocular iontophoretic device and method for inhibiting vascular endothelial growth factor (VEGF) using the same
